Comorbidities and mortality in COVID-19 patients

Area of Science:

• Medical Research
• Epidemiology
• Public Health

Background:

• High mortality in Coronavirus Disease (COVID-19) patients is linked to comorbid conditions.
• Identifying risk factors for poor COVID-19 outcomes is crucial.
• This study aimed to identify comorbidities in patients who died from COVID-19.

Purpose of the Study:

• To determine the prevalence of comorbidities in COVID-19 patients who died.
• To analyze the relationship between specific comorbidities and COVID-19 mortality.
• To assess the impact of multiple comorbidities on COVID-19 outcomes.

Main Methods:

• Retrospective descriptive study design.
• Inclusion of hospitalized COVID-19 patients from March to September 2020.
• Data collection on patient demographics, comorbidities, and mortality.

Main Results:

• Out of 454 patients, 78 (17.18%) died from COVID-19.
• The most prevalent comorbidities in deceased patients were hypertension (42.31%), cardiovascular disease (30.77%), and diabetes (28.21%).
• Over half of the deceased patients (52.56%) had two or more comorbidities.

Conclusions:

• Hypertension, cardiovascular disease, and diabetes are the most frequent comorbidities associated with COVID-19 mortality.
• The presence of multiple comorbidities significantly impacts the outcome of COVID-19 patients.
• These findings underscore the importance of managing comorbidities in COVID-19 patient care.